相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Eculizumab discontinuation in children and adults with atypical hemolytic-uremic syndrome: a prospective multicenter study
Fadi Fakhouri et al.
BLOOD (2021)
Eculizumab interruption in atypical hemolytic uremic syndrome due to shortage: analysis of a Brazilian cohort
Miguel Ernandes Neto et al.
JOURNAL OF NEPHROLOGY (2021)
Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes
Cinthia Montenegro Teixeira et al.
PLOS ONE (2020)
The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health
Rosangela Caetano et al.
REVISTA DE SAUDE PUBLICA (2020)
Brasil: the leading public kidney transplant program worldwide
Renato Demarchi Foresto et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2020)
Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome
Julien Zuber et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome
Andrew M. Siedlecki et al.
KIDNEY INTERNATIONAL REPORTS (2019)
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
M. Haas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Timothy H. J. Goodship et al.
KIDNEY INTERNATIONAL (2017)
Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndrome
Jan A. J. G. van den Brand et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice
Luis Gustavo Modelli de Andrade et al.
PLOS ONE (2017)
An international consensus approach to the management of atypical hemolytic uremic syndrome in children
Chantal Loirat et al.
PEDIATRIC NEPHROLOGY (2016)
A national specialized service in England for atypical haemolytic uraemic syndrome-the first year's experience
N. S. Sheerin et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2016)
Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome
Larry A. Greenbaum et al.
KIDNEY INTERNATIONAL (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort
A. Mallett et al.
INTERNAL MEDICINE JOURNAL (2015)
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies
Christoph Licht et al.
KIDNEY INTERNATIONAL (2015)
Atypical aHUS: State of the art
Carla M. Nester et al.
MOLECULAR IMMUNOLOGY (2015)
An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document
Josep M. Campistol et al.
NEFROLOGIA (2015)
Pharmacogenomics, human genetic diversity and the incorporation and rejection of color/race in Brazil
Ricardo Ventura Santos et al.
BIOSOCIETIES (2015)
Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab
Jacobien C. Verhave et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Genetics and Outcome of Atypical Hemolytic Uremic Syndrome: A Nationwide French Series Comparing Children and Adults
Veronique Fremeaux-Bacchi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
C. M. Legendre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation
J. Zuber et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
Julien Zuber et al.
NATURE REVIEWS NEPHROLOGY (2012)
Thrombotic Microangiopathy and Peritubular Capillary C4d Expression in Renal Allograft Biopsies
Shane M. Meehan et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
New insights into postrenal transplant hemolytic uremic syndrome
Julien Zuber et al.
NATURE REVIEWS NEPHROLOGY (2011)
Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
Marina Noris et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Thrombomodulin Mutations in Atypical Hemolytic-Uremic Syndrome
Mieke Delvaeye et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Screening for Partial Conjunction Hypotheses
Yoav Benjamini et al.
BIOMETRICS (2008)
分享论文
